From 2005 to 2021, alcohol-induced liver disease (AILD)-related hospitalizations and liver transplants (LTs) increased among women and men and in younger and older adults, according to a research ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led ...

Viking Therapeutics (VKTX) announced that final results from the company’s Phase 2b clinical trial of VK2809, the company’s novel ...

There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...

Chemomab Therapeutics (CMMB) announced that data from its Phase 2 SPRING trial in patients with primary sclerosing cholangitis was presented at ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint ... yet to share the data behind the ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the ...

AI can help doctors diagnose early cases of fatty liver disease, a new study says.An AI program trained to spot a lead ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect ...

Gilead shares data from its Phase 3 ASSURE study, showing 81% of PBC patients treated with Livdelzi achieved a composite ...

1Division of Digestive and Liver Diseases, Department of Medicine, Irving Cancer Research Center Columbia University Medical Center, New York, New York. 2Columbia University Digestive and Liver ...